Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Low and disparate seroprotection after pentavalent childhood vaccination in the Lao People's Democratic Republic: a cross-sectional study.

Evdokimov K, Sayasinh K, Nouanthong P, Vilivong K, Samountry B, Phonekeo D, Strobel M, Haegeman F, Heimann P, Muller CP, Black AP.

Clin Microbiol Infect. 2017 Mar;23(3):197-202. doi: 10.1016/j.cmi.2016.10.007. Epub 2016 Oct 15.

2.

Immunogenicity and reactogenicity of a combined fully liquid DTPw-HepB-Hib pentavalent vaccine in healthy infants: no clinically relevant impact of a birth dose of hepatitis B vaccine.

Gentile A, Umido V, Czerniuk P, Nacul J, Seigelchifer M, Hilbert AK, Yela U, Herzog C, Aeberhard U, Spyr C.

Int J Infect Dis. 2011 Jan;15(1):e24-9. doi: 10.1016/j.ijid.2010.09.004. Epub 2010 Nov 18.

3.

Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine.

Faingezicht I, Avila-Aguerro ML, Cervantes Y, Fourneau M, Clemens SA.

Rev Panam Salud Publica. 2002 Oct;12(4):247-57.

PMID:
12431356
4.

Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.

Halperin SA, Tapiéro B, Dionne M, Meekison W, Diaz-Mitoma F, Zickler P, Rubin E, Embree J, Bhuyan P, Lee A, Li M, Tomovici A.

Pediatr Infect Dis J. 2014 Jan;33(1):73-80. doi: 10.1097/01.inf.0000437806.76221.20.

PMID:
24346596
8.

Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).

Bar-On ES, Goldberg E, Hellmann S, Leibovici L.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD005530. doi: 10.1002/14651858.CD005530.pub3. Review.

PMID:
22513932
9.

The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.

Gatchalian S, Palestroque E, De Vleeschauwer I, Han HH, Poolman J, Schuerman L, Dobbelaere K, Boutriau D.

Int J Infect Dis. 2008 May;12(3):278-88. Epub 2007 Nov 5.

10.
11.

A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America.

Tregnaghi M, López P, Rocha C, Rivera L, David MP, Rüttimann R, Schuerman L.

Rev Panam Salud Publica. 2006 Mar;19(3):179-88.

PMID:
16640847
12.

A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth.

Gatchalian S, Reyes M, Bernal N, Lefevre I, David MP, Han HH, Bock HL, Wolter J, Schuerman L.

Hum Vaccin. 2005 Sep-Oct;1(5):198-203. Epub 2005 Sep 7.

PMID:
17012860
14.

Effect of prophylactic or therapeutic administration of paracetamol on immune response to DTwP-HepB-Hib combination vaccine in Indian infants.

Sil A, Ravi MD, Patnaik BN, Dhingra MS, Dupuy M, Gandhi DJ, Dhaded SM, Dubey AP, Kundu R, Lalwani SK, Chhatwal J, Mathew LG, Gupta M, Sharma SD, Bavdekar SB, Rout SP, Jayanth MV, D'Cor NA, Mangarule SA, Ravinuthala S, Reddy E J.

Vaccine. 2017 May 19;35(22):2999-3006. doi: 10.1016/j.vaccine.2017.03.009. Epub 2017 Apr 24.

15.

Four is better than nine. a combined diphtheria-tetanus-pertussis-hepatitis B-Haemophilus influenzae type b vaccine for routine immunization in Malaysia.

Wong SL, Soosai P, Teoh YL, Han HH, Lefevre I, Bock HL.

Southeast Asian J Trop Med Public Health. 2008 May;39(3):474-83.

PMID:
18564687
16.

A fully liquid DTPw-HepB-Hib combination vaccine for booster vaccination of toddlers in El Salvador.

Suárez E, Asturias EJ, Hilbert AK, Herzog C, Aeberhard U, Spyr C.

Rev Panam Salud Publica. 2010 Feb;27(2):117-24.

17.

Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy.

Simani OE, Izu A, Violari A, Cotton MF, van Niekerk N, Adrian PV, Madhi SA.

AIDS. 2014 Feb 20;28(4):531-41. doi: 10.1097/QAD.0000000000000127.

PMID:
24468996
18.

A new DTPw-HBV/Hib vaccine: immune memory after primary vaccination and booster dosing in the second year of life.

Gatchalian S, Reyes M, Bermal N, Chandrasekaran V, Han HH, Bock HL, Lefevre I.

Hum Vaccin. 2008 Jan-Feb;4(1):60-6. Epub 2007 Sep 23.

PMID:
18376148
19.

A phase III single arm, multicenter, open-label study to assess the immunogenicity and tolerability of a pentavalent DTwP-HepB-Hib vaccine in indian infants.

Eregowda A, Lalwani S, Chatterjee S, Vakil H, Ahmed K, Costantini M, Lattanzi M.

Hum Vaccin Immunother. 2013 Sep;9(9):1903-9. doi: 10.4161/hv.25166. Epub 2013 Jun 19.

20.

Safety and immunogenicity of two formulations of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae conjugate-hepatitis B vaccine in 15 to 18-month-old children.

Halperin SA, Langley JM, Hesley TM, Zappacosta PS, Radley D, Smith B, Hoffenbach A, Boslego J, Silber JL.

Hum Vaccin. 2005 Nov-Dec;1(6):245-50. Epub 2005 Nov 17.

PMID:
17012871

Supplemental Content

Support Center